| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
168 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
854 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
266 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
743 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
866 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6670355 |
Method of treating cardiovascular disease |
Dec. 30, 2003 |
| 6670371 |
Certain pyrrolopyridine derivatives: novel CRF1 specific ligands |
Dec. 30, 2003 |
| 6670384 |
Methods of administering epothilone analogs for the treatment of cancer |
Dec. 30, 2003 |
| 6667300 |
Inhibitors of human phosphatidylinositol 3-kinase delta |
Dec. 23, 2003 |
| 6667304 |
Polycyclic azaindole compounds |
Dec. 23, 2003 |
| 6664247 |
Pyrazole compounds useful as protein kinase inhibitors |
Dec. 16, 2003 |
| 6664248 |
2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides |
Dec. 16, 2003 |
| 6660727 |
Photochromic heterocyclically anellated indenochromene compounds |
Dec. 9, 2003 |
| 6660728 |
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
Dec. 9, 2003 |
| 6660740 |
Sorbitol dehydrogenase inhibitors |
Dec. 9, 2003 |
| 6656930 |
Aralkyl diazabicycloalkane derivatives for CNS disorders |
Dec. 2, 2003 |
| 6653295 |
Inhibitors of hepatitis C virus NS3 protease |
Nov. 25, 2003 |
| 6653299 |
Labelled factor XIIIa substrates |
Nov. 25, 2003 |
| 6653300 |
Pyrazole compounds useful as protein kinase inhibitors |
Nov. 25, 2003 |
| 6653301 |
Pyrazole compounds useful as protein kinase inhibitors |
Nov. 25, 2003 |
| 6653302 |
Quinoline and quinazoline compounds useful in therapy |
Nov. 25, 2003 |
| 6649607 |
Compositions and methods for treating or preventing convulsions or seizures |
Nov. 18, 2003 |
| 6649616 |
Substituted phenylcyclohexanecarboxamides and their use |
Nov. 18, 2003 |
| 6645774 |
Methods of modifying feeding behavior using compounds with afinity for the human hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
Nov. 11, 2003 |
| 6645917 |
Composition for hybrid seed production, process for the preparation of such composition and use thereof |
Nov. 11, 2003 |
| 6645956 |
Heteroaromatic derivatives having an inhibitory activity against HIV integrase |
Nov. 11, 2003 |
| 6645999 |
Lactacystin analogs |
Nov. 11, 2003 |
| 6641810 |
Methods of using geldanamycin and FK506 to treat peripheral nerve damage |
Nov. 4, 2003 |
| 6642211 |
Treatment of cancer with thymidine in combination with temozolamide |
Nov. 4, 2003 |
| 6638938 |
Method for preventing tissue injury from hypoxia |
Oct. 28, 2003 |
| 6635630 |
Selective neurokinin antagonists |
Oct. 21, 2003 |
| 6635637 |
Cyclic oxyguanidine protease inhibitors |
Oct. 21, 2003 |
| 6627624 |
Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
Sep. 30, 2003 |
| 6623724 |
Dermatological compositions and methods |
Sep. 23, 2003 |
| 6620804 |
Selenophene anti-tumor agents |
Sep. 16, 2003 |
| 6620818 |
Method for reducing the severity of side effects of chemotherapy and/or radiation therapy |
Sep. 16, 2003 |
| 6617333 |
Antineoplastic combinations comprising |
Sep. 9, 2003 |
| 6613759 |
Substance GM-95, process for producing the same and utilization thereof |
Sep. 2, 2003 |
| 6613760 |
Indole derivatives and their use as MCP-1 receptor antagonists |
Sep. 2, 2003 |
| 6610677 |
Pyrazole compounds useful as protein kinase inhibitors |
Aug. 26, 2003 |
| 6610678 |
CRF antagonistic quino-and quinazolines |
Aug. 26, 2003 |
| 6610694 |
Condensed pyridazine compounds, their production and use |
Aug. 26, 2003 |
| 6608048 |
Tricyclic protein kinase inhibitors |
Aug. 19, 2003 |
| 6608063 |
Pyrazine based inhibitors of glycogen synthase kinase 3 |
Aug. 19, 2003 |
| 6608066 |
Tissue factor antagonists and methods of use thereof |
Aug. 19, 2003 |
| 6605599 |
Epothilone derivatives |
Aug. 12, 2003 |
| 6602862 |
1-Amino-alkylcyclohexanes as trypanocidal agents |
Aug. 5, 2003 |
| 6602863 |
Irreversible inhibitors of tyrosine kinases |
Aug. 5, 2003 |
| 6602889 |
5-heteroaryl substituted indoles |
Aug. 5, 2003 |
| 6599890 |
Arylsulfonyl hydroxamic acid derivatives |
Jul. 29, 2003 |
| 6599891 |
Treatment of macular edema |
Jul. 29, 2003 |
| 6599906 |
Method of local anesthesia and analgesia |
Jul. 29, 2003 |
| 6596714 |
Parasiticidal formulation for animals and a method of making this formulation |
Jul. 22, 2003 |
| 6592884 |
Method of using alpha-keto enamine derivatives as ingredients and products incorporating same |
Jul. 15, 2003 |
| 6593314 |
Neuraminidase inhibitors |
Jul. 15, 2003 |
|
|
|
